CM Life Sciences, Inc. (CMLFU) es una empresa que cotiza en bolsa en el Servicios Financieros sector, operando dentro de la Shell Companies industria. La empresa tiene su sede en New York City, NY, United States. El CEO actual es Eli Decatur Casdin.
CMLFU tiene fecha de IPO 2020-09-02, cotiza en el NASDAQ Capital Marke, una capitalización de mercado de $10.31B.
CM Life Sciences, Inc. is a special purpose acquisition company (SPAC) founded in 2020 and headquartered in New York, New York. The company was established to identify and execute a merger or business combination with one or more operating companies, potentially involving capital stock exchanges, asset acquisitions, or stock purchases. Through this acquisition strategy, CM Life Sciences seeks to create value in the life sciences sector by combining with established or emerging businesses.
